androgen receptor pathway inhibitors (ARPIs)
Cancer
Hormone-sensitive prostate cancer
multimodal therapy survival outcomes
personalized treatment intensification
PSMA PET imaging
Tailored Treatment Boost for Hormone-Sensitive Prostate Cancer
In the evolving landscape of prostate cancer treatment, hormone-sensitive prostate cancer (HSPC) has traditionally been managed with androgen-deprivation therapy (ADT) as a monotherapy. For decades, ADT was the cornerstone of…